Organic sodium salts
Sigma Aldrich Fine Chemicals Biosciences Dextran Sulfate Sodium Salt from Leuconostoc spp. | 9011-18-1 | MFCD00081551 | 50g
Dextran Sulfate Sodium Salt from Leuconostoc spp. | 9011-18-1 | MFCD00081551 | 50g
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 5 MG
CNQX disodium (FG9065 disodium) is a potent and competitive AMPA/kainate receptor antagonist. It blocks the expression of fear-potentiated startle in rats and is a competitive non-NMDA receptor antagonist. It is suitable for in vitro and in vivo research.
- Potent and competitive AMPA/kainate receptor antagonist
- Blocks expression of fear-potentiated startle
- Competitive non-NMDA receptor antagonist
- Suitable for neurological disease research
- Inhibitor of ionotropic glutamate receptors
TARGETMOL CHEMICALS INC NBQX DISODIUM 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg and bulk. Please contact Fisher for quotes. NBQX Disodium (FG9202 disodium) is a highly selective competitive AMPA receptor antagonist with neuroprotective and anticonvulsant activity. NBQX Disodium is a salt of NBQX. NBQX is a potent and selective AMPA/rhodosinate receptor antagonist that can be used to antagonize the excitatory toxicity of glutamate. It has anticonvulsant effects in rodent models. purity: 98%
Pfaltz & Bauer Dimethylglyoxime Sodium Salt 100G | 60908-54-5
Dimethylglyoxime Sodium Salt 100G | 60908-54-5
TARGETMOL CHEMICALS INC CNQX 25MG
Also available in 5 mg 10 mg 50 mg 100 mg 200 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. CNQX (FG9065) is a competitive non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 uM for AMPA and kainate receptors respectively)purity: 98%
Apexbio Technology LLC CNQX 115066-14-3 10mg
CNQX (CAS 115066-14-3) is a selective and competitive antagonist of AMPA and kainate subtype ionotropic glutamate receptors In hippocampal slice preparations superfusion with CNQX at concentrations of 2 5 M reversibly inhibits excitatory post-synaptic potentials mediated by Schaffer collaterals and mossy fibers while preserving both fast and slow GABAergic inhibitory responses In behavioral studies bilateral infusion of CNQX into the amygdala or dorsal hippocampus prior to testing partially suppresses the expression of conditioned avoidance responses with complete blockade observed at specific doses CNQX is widely utilized to dissect excitatory synaptic transmission and investigate non-NMDA receptor functions in neurophysiological and behavioral research
Medchemexpress LLC DNQX (FG 9041) | 2379-57-9 | C8H4N4O6 | 100 MG
DNQX (FG 9041) is a quinoxaline derivative that functions as a selective, potent competitive non-NMDA glutamate receptor antagonist. It exhibits IC50 values of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors, respectively. This compound is known to selectively depolarize thalamic reticular nucleus (TRN) neurons.
- Selective, potent competitive non-NMDA glutamate receptor antagonist
- Exhibits IC50s of 0.5, 2, and 40 μM for AMPA, kainate, and NMDA receptors
- Selectively depolarizes thalamic reticular nucleus (TRN) neurons
- Purity of 99.67%
- Molecular weight of 252.14
- Appears as a white to off-white solid
Apexbio Technology LLC CNQX 115066-14-3 50mg
CNQX (CAS 115066-14-3) is a selective and competitive antagonist of AMPA and kainate subtype ionotropic glutamate receptors In hippocampal slice preparations superfusion with CNQX at concentrations of 2 5 M reversibly inhibits excitatory post-synaptic potentials mediated by Schaffer collaterals and mossy fibers while preserving both fast and slow GABAergic inhibitory responses In behavioral studies bilateral infusion of CNQX into the amygdala or dorsal hippocampus prior to testing partially suppresses the expression of conditioned avoidance responses with complete blockade observed at specific doses CNQX is widely utilized to dissect excitatory synaptic transmission and investigate non-NMDA receptor functions in neurophysiological and behavioral research
Medchemexpress LLC Cnqx | 115066-14-3 | C9H4N4O4 | 50 MG
CNQX is a potent and competitive AMPA/kainate receptor antagonist. It has IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors, and also acts as a competitive non-NMDA receptor antagonist.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50s of 0.3 μM for AMPA and 1.5 μM for kainate receptors
- Acts as a competitive non-NMDA receptor antagonist
- Blocks the expression of fear-potentiated startle in rats
- Reversibly blocks Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP)
- Selectively reduces the amplitude of the monosynaptic component of DR-VRR
Medchemexpress LLC NBQX (disodium) | 479347-86-9 | MFCD00220677 | C12H6N4Na2O6S | 100 MG
NBQX disodium (FG9202 disodium) is a highly selective and competitive AMPA receptor antagonist, known for its neuroprotective and anticonvulsant activities. This compound demonstrates a high affinity for AMPA and kainate binding sites, while showing minimal affinity for the glutamate recognition site on the NMDA receptor complex. Research indicates its effectiveness in protecting against focal ischaemia and reducing seizures in experimental models.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective properties
- Shows anticonvulsant efficacy
- Possesses high affinity for AMPA and kainate binding sites
- Low affinity for NMDA receptor complex